FDA NDC Directory · JSON-LD · Markdown

Deflazacort Oral Suspension

NDC 57664-993 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Generic nameDeflazacort Oral
Labeler / ManufacturerSun Pharmaceutical Industries, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA219930
Dosage form / routeSUSPENSION · ORAL
Active ingredientsDEFLAZACORT (22.75 mg/mL)
Marketing started20260202
Package count1

External sources

Source: openFDA. Public-domain (CC0).